Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer JU Jeong, TK Nam, HR Kim, HJ Shim, YH Kim, MS Yoon, JY Song, ... Radiation Oncology 11, 1-8, 2016 | 34 | 2016 |
Evaluation of prognostic factors for the parotid cancer treated with surgery and postoperative radiotherapy YH Kim, WK Chung, JU Jeong, IJ Cho, MS Yoon, JY Song, TK Nam, ... Clinical and experimental otorhinolaryngology 13 (1), 69, 2020 | 18 | 2020 |
Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation YH Kim, SJ Ahn, YC Kim, KS Kim, IJ Oh, HJ Ban, WK Chung, TK Nam, ... Japanese Journal of Clinical Oncology 46 (2), 144-151, 2016 | 17 | 2016 |
Randomized, multicenter, phase 3 study of accelerated fraction radiation therapy with concomitant boost to the gross tumor volume compared with conventional fractionation in … YH Kim, SJ Ahn, SH Moon, JH Kim, YC Kim, IJ Oh, CK Park, JU Jeong, ... International Journal of Radiation Oncology* Biology* Physics 115 (4), 873-885, 2023 | 9 | 2023 |
Radiation hardness of cadmium telluride solar cells in proton therapy beam mode S Cho, SH Ahn, IJ Cho, YH Kim, JU Jeong, MS Yoon, SJ Ahn, WK Chung, ... PLoS One 14 (9), e0221655, 2019 | 9 | 2019 |
Effect of novel double treatment on the properties of CdTe solar cells S Kim, JY Song, D Kim, J Hong, IJ Cho, YH Kim, JU Jeong, MS Yoon, ... Energy Reports 7, 1396-1403, 2021 | 8 | 2021 |
Intensity-modulated radiotherapy for stage I glottic cancer: a short-term outcomes compared with three-dimensional conformal radiotherapy IJ Cho, WK Chung, JK Lee, MC Lee, J Paek, YH Kim, JU Jeong, MS Yoon, ... Radiation Oncology Journal 37 (4), 271, 2019 | 8 | 2019 |
Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy JU Jeong, TK Nam, JY Song, MS Yoon, SJ Ahn, WK Chung, IJ Cho, ... Radiation Oncology Journal 37 (3), 215, 2019 | 8 | 2019 |
Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer YH Kim, SY Song, HJ Shim, WK Chung, SJ Ahn, MS Yoon, JU Jeong, ... Radiation oncology journal 33 (1), 12, 2015 | 7 | 2015 |
A phase I/II trial to evaluate the technical feasibility of partial breast irradiation with three-dimensional conformal radiation therapy in Korean women with stage I breast … JU Jeong, JH Yoon, MH Park, MS Yoon, JY Song, TK Nam, WK Chung, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2015 | 7 | 2015 |
Korean real-world data on patients with unresectable stage III NSCLC treated with durvalumab after chemoradiotherapy: PACIFIC-KR CK Park, HJ Oh, YC Kim, YH Kim, SJ Ahn, WG Jeong, JY Lee, JC Lee, ... Journal of Thoracic Oncology 18 (8), 1042-1054, 2023 | 6 | 2023 |
Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET SG Cho, YH Kim, H Park, KS Park, J Kim, SJ Ahn, HS Bom Annals of Nuclear Medicine 36 (5), 439-449, 2022 | 5 | 2022 |
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy IJ Cho, JU Jeong, TK Nam, YE Joo, SB Cho, YH Kim, JY Song, MS Yoon, ... Radiation Oncology Journal 40 (1), 20, 2022 | 4 | 2022 |
Effect of interstitial lung abnormality on concurrent chemoradiotherapy-treated stage III non-small cell lung cancer patients WG Jeong, YH Kim, SJ Ahn, JU Jeong, BC Lee, IJ Cho, YH Kim Anticancer Research 43 (4), 1797-1807, 2023 | 3 | 2023 |
A propensity-matched retrospective comparative study with historical control to determine the real-world effectiveness of durvalumab after concurrent chemoradiotherapy in … CK Park, N Jeon, HK Park, HJ Oh, YC Kim, HL Jeon, YH Kim, SJ Ahn, ... Cancers 15 (5), 1606, 2023 | 3 | 2023 |
Blood-based biomarker analysis for predicting efficacy of chemoradiotherapy and durvalumab in patients with unresectable stage III non-small cell lung cancer CK Park, SW Lee, HJ Cho, HJ Oh, YC Kim, YH Kim, SJ Ahn, JH Cho, ... Cancers 15 (4), 1151, 2023 | 3 | 2023 |
Dosimetric analysis on the effect of tumor motion in IMRT for liver cancer: comparison of TomoTherapy and VMAT using the Delta4 Hexa-Motion system S Cho, IJ Cho, YH Kim, JU Jeong, MS Yoon, SJ Ahn, TK Nam, JY Song Journal of the Korean Physical Society 79, 477-484, 2021 | 2 | 2021 |
Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high-or very … JU Jeong, TK Nam, JY Song, MS Yoon, SJ Ahn, WK Chung, IJ Cho, ... Plos one 16 (3), e0248461, 2021 | 2 | 2021 |
Blood lymphocytes as a prognostic factor for stage III non-small cell lung cancer with concurrent chemoradiation YH Kim, YD Choi, SJ Ahn, YC Kim, IJ Oh, TK Nam, JU Jeong, JY Song Chonnam Medical Journal 60 (1), 40, 2024 | 1 | 2024 |
Analyzing the effect of liver-tumor motion on the dosimetric error in intensity-modulated radiation therapy using the Halcyon linear accelerator S Cho, IJ Cho, YH Kim, JU Jeong, MS Yoon, TK Nam, SJ Ahn, JY Song Journal of the Korean Physical Society 81 (2), 158-165, 2022 | 1 | 2022 |